Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 131-144, March 2007

Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours

  • Tim Meyer, PhD, MRCP (Senior Lecturer in Oncology)
  • Martyn E. Caplin, DM, FRCP (Consultant Gastroenterologist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 77940500x35230; Fax: +44 20 7472 6728.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, Pond Street, London NW3 2QG, UK

Department of Oncology, Royal Free Hospital, London NW3 2QG, UK

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, Pond Street, London NW3 2QG, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00006-1

doi:10.1016/j.beem.2007.01.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 131-144, March 2007

Article Tools